Background/Objectives: This cohort study was conducted to evaluate the effect of waist change on metabolic syndrome (MetS) status and its parameters in 5720 participants, aged X20 years, of the Tehran Lipid and Glucose Study who were followed up for a mean of 6.6 years. Subjects/Methods: We measured waist circumference (WC) and MetS parameters at baseline (phase I: 1999) and at follow-up (phase III: 2008), and assessed this relationship across five groups: waist loss (oÀ2.0 cm); waist stable (À2.0 to 2.9 cm); mild (3.0-5.9 cm); moderate (6.0-8.9 cm) and large (X9.0 cm) waist gain. MetS was defined according to the International Diabetes Federation criteria. Results: In phase I, the mean (s.d.) waist gain was 88.8 cm (11.7). Between phases I and III, the mean (s.d.) waist gain was 5 cm (7.9). There was 16% (95% confidence interval (95% CI): 13.6-18.4) age-adjusted incident MetS and for every centimeter of WC gained over 6.6 years, the risk of MetS increased by 10% (odds ratio (OR) 1.10; 95% CI: 1.09-1.12). Compared with a stable WC in both genders, ORs for MetS for different waist gain groups were as follows: mild (OR 2.3, 95% CI: 1.7-3.2); moderate (OR 3.5, 95% CI: 2.6-4.7) and large (OR 5.8, 95% CI: 4.5-7.6). Waist loss had a protective effect on MetS (OR 0.6, 95% CI: 0.4-0.9). Waist gain showed a detrimental effect on all parameters of MetS in both genders, except for high-density lipoprotein cholesterol and fasting blood sugar in women. Conclusions: Waist gain, even mild, was a risk factor of the development of MetS and its parameters. Intervention for reducing WC could be an effective strategy to decrease incident MetS.
Introduction
Metabolic syndrome (MetS) is a set of disorders including abdominal obesity, high blood pressure (BP), increased glucose concentration and dyslipidemia and is associated with a doubled risk for developing type II diabetes mellitus (Liu et al., 2008) and cardiovascular disease (Dekker et al., 2005) , especially stroke (Hsin-Jen et al., 2006) . Abdominal obesity has been known as an important risk factor for MetS (Nakamura et al., 2008) . It has been suggested that waist gain increases the risk of developing hyperinsulinemia which, in turn, is associated with MetS (Hayashi et al., 2008) . Although many studies (Meigs et al., 2007; Smith and Haslam, 2007; Pettman et al., 2009) have reported cross-sectional associations between MetS parameters, few have prospectively examined the development of MetS in a cohort. Furthermore, the role of waist change in the etiology of this syndrome is poorly understood and limited to only a few cohort studies (Mayer-Davis et al., 2003; Balkau et al., 2007; Cameron et al., 2008) . Therefore, it seems that investigations are essential to clarify the relationship between waist change and MetS and its parameters. Although abdominal obesity is closely associated with MetS, the extent of global risk for MetS parameters associated with differing degrees of abdominal obesity is not well described in a population representative sample of Iranian adults.
The primary aim of this study was to investigate men and women who gained and lost abdominal obesity over 6.6 years of follow-up and to describe the incidence and the improvement in MetS, according to changes in waist circumference (WC). A secondary aim was to determine the impact of gender-stratified waist change on incidence or improvement of the syndrome itself and its parameters in participants of the Tehran Lipid and Glucose Study (TLGS).
Materials and methods

Study cohort
We used metabolic and anthropometric data from phases I and III of TLGS, which is a large cohort, representative of the Tehranian population. Detailed descriptions of data collection procedures and study variables are available in previous reports (Azizi et al., 2000 (Azizi et al., , 2009 . The TLGS is an ongoing study being conducted to determine the prevalence of non-communicable diseases and the risk factors of atherosclerosis among Tehran's urban population and to develop population-based measures and lifestyle modifications to decrease the prevalence and prevent the increasing trend of diabetes mellitus and dyslipidemia. Tehran, the capital of Iran, is a metropolitan city (with a population of B12 million) composed of 20 urban districts, including district 13 in the eastern part of the city. District 13 was chosen for the study for two reasons: (1) high stability of the population residing in this district and (2) the age distribution of this district is representative of Tehran's population. The design of this study includes two major components, a cross-sectional prevalence study of cardiovascular disease and associated risk factors and, a prospective 20-year followup in several phases, phase I in 1999 -2001 , phase II in 2002 and phase III in 2006 , at B3.6-year intervals.
Study subjects
Of the original cohort of TLGS participants, 10 368 aged X20 years, 5855 (56.5%) were seen at the follow-up examination. After excluding underweight subjects (body mass index (BMI) o18.5 kg/m 2 ; n ¼ 135), because of potential confounding with parameters due to concurrent illness, data of 5720 subjects with complete 6.6-year follow-ups were used in this cohort study. We evaluated the relationship of waist change with the MetS over a period of 6.6 years in the participants, who had complete data on weight, height, WC, BP, glucose and lipid profile in both phases I and III.
At the beginning of phase I, all participants provided written informed consent, and the study was approved by the institutional ethics committees (Research Institute for Endocrine Sciences affiliated to Shahid Beheshti University of Medical Sciences) and conducted in accordance with the principles of the Declaration of Helsinki.
Measurement
Although the subjects were minimally clothed and not wearing shoes, weight was measured using digital scales (Seca 707, Hanover, MD, USA), and recorded to the nearest 100 g. WC was measured at the umbilical level, using an unstretched tape meter, without any pressure to body surface, and was recorded to the nearest 0.1 cm (Azizi et al., 2000) . The reproducibility of WC measurements is high for both men and women, intra-class correlation coefficient, r ¼ 0.998 and r ¼ 0.999, respectively (Klein et al., 2007) . To reduce subjective error, all measurements were taken by trained technicians. Instruments and methods used for anthropometric measurements were same in both baseline and follow-up (Azizi et al., 2009) . Systolic BP and diastolic BP were measured twice after the participants sat for 15 min (Azizi et al., 2009) , when a qualified physician measured BP twice in a seated position, using a standard mercury sphygmomanometer on the right arm, and the mean of the two measurements was considered as the participant's BP. There were significant correlations between the test and retest results taken by the technicians (r40.75, Po0.01).
Smoking and physical activity were assessed using questionnaires. Smoking was defined according to WHO (World health Organization) guidelines (WHO, 1998) , in which a daily smoker is defined as one who smokes at least once a day; the occasional smoker as someone who smokes cigarettes but not every day; an ex-smoker is a former daily or occasional smoker, who currently does not smoke; and non-smoker is someone who never smoked before or smoked very little in the past. In our questionnaire, smoking was categorized into Yes/No groups; 'Yes' defined participants who smoked cigarettes (daily or occasionally), and 'No' defined nonsmokers or ex-smokers. Physical activity level was determined using the Lipid Research Clinics (Ainsworth et al., 1993) questionnaire, a simple and comprehensible measure including four questions; no special education was required to complete this questionnaire, which categorized individuals into three groups of light, moderate and heavy physical activity.
After 12-14 h overnight fasting for biochemical analysis, blood samples were collected in a standard sitting position and then centrifuged during 45 min after collection. All the assays including fasting blood sugar (FBS), triglyceride (TG) and high-density lipoprotein (HDL) cholesterol (HDL-C), were performed on the day of sampling; FBS was measured by glucose oxidase method (Glucose kit, Pars Azmun, Tehran, Iran), the method sensitivity and intra-and intercoefficients of variation for baseline and follow-up examination were 1 mg/dl, 2.2 and 3.3% respectively. TG levels of the samples were determined by enzymatic colorimetric method (TG kit, Pars Azmun), the method sensitivity, intra-and inter-coefficients of variation for baseline and follow-up examination were 1 mg/dl, 1.6 and 3.9% respectively; HDL-C was measured by the precipitation and enzymatic colorimetric method (HDL-C kit, Pars Azmun), the method sensitivity and coefficient of variation were 1 mg/dl and 2.1% respectively. All the assays were performed using an Auto analyzer (Selectra II, Merck, Dieren, The Netherlands). The method used for glucose and lipid measurement was the same at both baseline and follow-up.
Definitions
MetS was defined by the criteria of the IDF (International Diabetes Federation) (Alberti et al., 2005) . In our study based on the original definition of IDF, abdominal obesity was identified by WC X94 cm for men and X80 cm for women.
Waist change was divided into five groups that were clinically significant: (1) waist loss (oÀ2.0 cm); (2) waist stable reference group (À2.0 to þ 2.9 cm); (3) mild waist gain (3.0-5.9 cm); (4) moderate waist gain (6.0-8.9 cm); and (5) large waist gain (X9.0 cm).
Statistical analysis
All continuous data are expressed as mean±s.d. and categorical variables are expressed as percentage. Logarithmic transformation was performed to normalize the distribution of TGs. Geometric means and s.e. of geometric means are presented for serum TG levels. Paired t-tests and MacNemar tests were used to compare changes during follow-up. Gender-stratified analyses of MetS and all parameters within waist-change groups were performed. General linear models were used to estimate age-adjusted means of the individual MetS parameters at the 6.6-year examination (phase III according to the different waist-change groups).
Logistic regression models were developed to assess the role of waist changes in the incidence and improvement of MetS parameters. Adjustments were made for smoking, physical activity, BMI at baseline and BMI change. We also assessed the impact of a 1 cm waist change on incident MetS. To evaluate the relationships between waist-change groups and the status of MetS in phases I and III were defined four definitions as follows: (1) remaining stable and normal (no MetS at phase I or phase III); (2) improvement MetS (MetS at phase I but not at phase III); (3) incident MetS (normal at phase I but MetS present at phase III); and (4) remaining stable in abnormal (MetS present at both phases I and III).
Significance was considered to be Po0.05. All statistical analyses were performed using SPSS 15.0 software for Windows (SPSS Inc., Chicago, IL, USA).
Results
Of 5720 subjects at baseline, with an average age of 42.3 ± 13.2 years and WC of 88.8 ± 11.7 cm, 42.2% (n ¼ 2358) were men. After 6.6 years of follow-up, the cohort gained a mean waist of 5 cm (7.4 in men and 3.4 in women). Furthermore, WC was increased by X3 cm in 79.9% (n ¼ 1882) of men and 54.1% (n ¼ 1819) of women, respectively. Of subjects, 14.4% (n ¼ 824) decreased their waist by oÀ2 cm, and 20.9% (n ¼ 1195) remained stable. Table 1 shows baseline categories of different waist-change groups at baseline with increasing levels of waist across different groups all parameters of MetS, except systolic BP in men.
After adjusting for age and baseline variables, there was a strong linear trend with increasing waist gain and worsening of all MetS parameters among both men and women, except for HDL-C and FBS in women ( Table 2) .
The incidence of MetS was 16% (95% confidence interval (95% CI): 13.6-18.4) (22.4% for men and 11.5% for women) ( Table 3 ). The odds ratios (ORs) (95% CI) for incident MetS were 9.8 (6.0-16.0) in men and 3.7 (2.7-5.1) in women who increased their waist by X9 cm, compared with a stable WC. Even mild waist gain was associated with incidence of MetS (overall OR 2.3; 95% CI: 1.7-3.2), compared with a stable WC. After adjustment for age, for every centimeter waist gained over the 6.6-year period, the risk of incident MetS increased 10%, and this risk was the same for both men and women (overall OR 1.10; 95% CI: 1.09-1.12). Moreover, according all risk factors, hypertriglyceridemia in both genders, 12 and 11.3% in men and women, respectively, and high BP and low HDL-C in men (12%) had the highest incidence at the end of follow-up. An increasing trend for ORs was observed for all variables, except for HDL-C in women and FBS in men; further adjustment for baseline BMI, smoking habits or physical activity did not change this association. However, after adjusting for the 6.6-year BMI change, among five components of MetS, OR for hypertriglyceridemia in men (P ¼ 0.02), but not in women, remained statistically significant (data not shown).
Of those abdominally obese at baseline, 1.3% of men and 4.4% of women improved after 6.6 years (Table 4) , hypertriglyceridemia and high BP showing the most improvement (13.2 and 12.7%, respectively). A decreasing WC was beneficially associated with all MetS parameters in men, whereas in women, it was associated with TGs and FBS. Further adjustment for baseline BMI, smoking and physical activity did not alter these results, but after adjustment for change in BMI, the associations remained significant for TG and HDL-C in women and for TG and FBS in men (data not shown).
Increasing waist gain was associated with higher rates of both developing and maintaining the syndrome, if present at baseline. Reversion to normal among those who had the syndrome at baseline was much more frequent among the waist loss group (Po0.0001, Figure 1) . Furthermore, the ageadjusted incidence rates (95% CI) of MetS by waist-change groups were: 60.2% in the waist gain group vs 6.3% in the waist stable group. On the other hand, 21% of MetS improvements occurred in the waist loss group vs 9.6% in the waist stable one.
Discussion
Our findings in this population-based cohort study after 6.6 years of follow-up, suggest that there is a strong positive Waist change and metabolic syndromeassociation between waist gain and development of MetS and also worsening of majority of its parameters. Compared with a stable WC, the OR for incident MetS in large waist gain was 5.8; even mild waist gain can have a significant effect on MetS and its parameters. On the other hand, compared with a stable WC, the OR for improvement of MetS in waist loss group was 2.5.
WC as a surrogate of abdominal obesity (Han et al., 1997) has been suggested as a driver of cardiometabolic risks. As intra-abdominal fat (mesenteric and omentum fat) has shown high activities of both lipogenesis and lipolysis, its accumulation can induce high levels of free fatty acids (van Harmelen et al., 2002) , a product of lipolysis, in portal circulation which go to the liver. Excess free fatty acids may cause the enhancement of lipid synthesis and gluconeogenesis, as well as insulin resistance, resulting in hyperlipidemia, glucose intolerance and hypertension and finally atherosclerosis; this could also be through secretion of a series of biologically active molecules (adipokines) (Yatagai et al., 2003; Kershaw and Flier, 2004) and induction of chronic low-grade systemic inflammatory mediator (Bertin et al., 2000; van Harmelen et al., 2002) . As a result, increase in abdominal obesity could explain the increase in the incidence of MetS and cardiometabolic risks in our population study during this short period of follow-up.
Recently, the effect of waist gain on the development of MetS and all its parameters has been evaluated by a few cohort studies (Mayer-Davis et al., 2003; Balkau et al., 2007; Cameron et al., 2008) , which are very distinct from each other regarding differences in population characteristics, the time period between the two waist measurements, the lengths of follow-up, waist-change expression method and different criteria for MetS definitions. In the study by Balkau et al. (2007) which followed a French population of 3807 individuals aged 30-64 years at baseline, over a period of 9 years, MetS was defined according to the NCEP (National Cholesterol Education Program); they reported that waist gain was associated with insulin resistance developing in the Waist change and metabolic syndrome F Hosseinpanah et al
French adults, findings that also suggest that waist gain may precede the development of insulin resistance. Our findings are almost in agreement with this cohort study in which waist gain even by X3 cm had significant effect on MetS in both genders so as an increase of X9 cm. In addition, there was a strong inverse linear trend with waist gain and 
915/4800 (19.8) 0.6 (0.4-0.9) 1 2.3 (1.7-3.2) 3.5 (2.6-4.7) 5.8 (4.5-7.6) o0.001 FBSX100 (mg/dl) 531/5185 (9.3) 0.7 (0.5-0.9) 1 1.1 (0.8-1.5) 1.1 (0.8-1.5) 1.5 (1.1-1.9) 0.001 HDL-C o40 (mg/dl) 618/5098 (10.8) 1.0 (0.8-1.4) 1 1.1 (0.8-1.5) 1.1 (0.9-1.5) 1.4 (1.1-1.8) 0.03 TG4150 (mg/dl) 664/5046 (11.6) 0.7 (0.5-1.0) 1 1.2 (0.9-1.6) 1.5 (1.1-1.9) 1.9 (1.5-2. Waist change and metabolic syndrome F Hosseinpanah et al Figure 1 Association between waist change and presence ( þ ) or absence (À) of the metabolic syndrome (MetS) among 5720 TLGS participants between baseline (phase I) and the 6.6-year follow-up examination (phase III). Waist loss (p2 cm), waist stable (À2 to þ 2 cm), mild-to-moderate waist gain (3-8 cm), large waist gain (X9 cm). Stable and normal (no MetS at phase I or phase III); improvement MetS (MetS at phase I but not at phase III); incident MetS (normal at phase I but MetS present at phase III); and remaining stable in abnormal (MetS present at both phase I and phase III). *Po0.001 within waist-change groups.
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